Allergy Therapeutics Shares Fall on Lower FY 2023 Revenue, Swing to Loss

By Ian Walker Shares of Allergy Therapeutics slid as much as 16% in early trade after the company said that revenue for fiscal 2023 fell due to a pause in...

Related Keywords

Ian Walker , ,Allergy Therapeutics ,Article Normal ,Biotechnology Services ,Healthcare Life Sciences ,Financial Performance ,Earnings ,Sales Figures ,Earnings Surprises ,Share Price Movement Disruptions ,Corporate Industrial News ,Allergies ,Political General News ,Health ,Medical Conditions ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Political ,General News ,Commodity ,Financial Market News ,Healthcare ,Life Sciences ,